Ascendis Health (JSE:ASC) Other Long-Term Liabilities: R8 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:ASC Ascendis Health Ltd JSE:ASC
11 GF Score
Price R0.92
View Full Analysis

What is Ascendis Health Other Long-Term Liabilities?

Ascendis Health JSE:ASC 11 Other Long-Term Liabilities is R8 Mil as of Jun. 2023. GuruFocus rates JSE:ASC with a GF Score™ of 11/100.

Ascendis Health's other long-term liabilities for the quarter that ended in Jun. 2023 was R8 Mil.

Ascendis Health's quarterly other long-term liabilities declined from Jun. 2022 (R25 Mil) to Dec. 2022 (R24 Mil) and declined from Dec. 2022 (R24 Mil) to Jun. 2023 (R8 Mil).

Ascendis Health's annual other long-term liabilities declined from Jun. 2021 (R77 Mil) to Jun. 2022 (R25 Mil) and declined from Jun. 2022 (R25 Mil) to Jun. 2023 (R8 Mil).

Ascendis Health Other Long-Term Liabilities Related Terms

Ascendis Health Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Ascendis Health's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Health Other Long-Term Liabilities Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 603.52 1,328.41 76.77 24.77 8.10

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.77 69.05 24.77 23.65 8.10
JSE:ASC
11GF Score
Ascendis Health Ltd JSE:ASC
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Health Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of R8 Mil mean?
Ascendis Health (JSE:ASC) has a Other Long-Term Liabilities of R8 Mil as of Jun. 2023. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ascendis Health and its competitors.
Is Ascendis Health's Other Long-Term Liabilities too high?
Ascendis Health's current Other Long-Term Liabilities is R8 Mil. Overall, Ascendis Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Health's Other Long-Term Liabilities compare to PHBI and GCAN?
Ascendis Health's Other Long-Term Liabilities of R8 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Distribution company?
A good Other Long-Term Liabilities depends on the Medical Distribution industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ascendis Health and its competitors. Ascendis Health's current Other Long-Term Liabilities is R8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Health stock overvalued right now?
Ascendis Health (JSE:ASC) has a current Other Long-Term Liabilities of R8 Mil. The current Other Long-Term Liabilities is R8 Mil. Ascendis Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Ascendis Health (JSE:ASC), the current Other Long-Term Liabilities is R8 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Health Business Description

Address 1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health Ltd is a health and wellness investment holding Company that holds investments in a number of companies that market and distribute a portfolio of brands, products, and medical devices. The company operates in two segments: i) Consumer Health (wellness, health supplements, speciality ingredients and compounded medicines) and ii) Medical Devices (distributor of medical devices, in vitro diagnostic products and orthopaedic equipment). The company generates the majority of its revenue from the Medical Devices segment.
11GF Score

Get the complete analysis for JSE:ASC

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.92
Price